Current understanding and management of nasopharyngeal carcinoma. - Wikidata - wikimedia - TriplyDB

Current understanding and management of nasopharyngeal carcinoma.

Current understanding and management of nasopharyngeal carcinoma.

http://www.wikidata.org/entity/Q37877020

about

An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site - current status and challenges.Concurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled study.MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2 DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma Identification of patients with nasopharyngeal carcinoma by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population SOX1 down-regulates β-catenin and reverses malignant phenotype in nasopharyngeal carcinoma.Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells.Serum alkaline phosphatase predicts survival outcomes in patients with skeletal metastatic nasopharyngeal carcinoma.Nanoparticle-mediated down-regulation of TWIST increases radiosensitivity of nasopharyngeal carcinoma cells via ERK pathway Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing.No association between TGF-β1 polymorphisms and risk of nasopharyngeal carcinoma in a large North African case-control study Association of CELF2 polymorphism and the prognosis of nasopharyngeal carcinoma in southern Chinese population.Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma.miR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22 Label-free blood plasma test based on surface-enhanced Raman scattering for tumor stages detection in nasopharyngeal cancer.Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications.Refractory nasopharyngeal carcinoma: positron emission tomography combined with computed tomography-guided 125I seed implantation therapy after repeated traditional radiochemotherapy.miR-346 promotes migration and invasion of nasopharyngeal carcinoma cells via targeting BRMS1.Progress and controversy for the role of chemotherapy in nasopharyngeal carcinoma.PARP-1 promotes autophagy via the AMPK/mTOR pathway in CNE-2 human nasopharyngeal carcinoma cells following ionizing radiation, while inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells.Fluorescence visualization screening for EBV-LMP1-targeted DNAzymes.Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma.Improved antitumor effect of ionizing radiation in combination with rapamycin for treating nasopharyngeal carcinoma.Nasopharyngeal carcinoma signaling pathway: an update on molecular biomarkers.Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.The changing role of surgery in the current era of head and neck oncology.Modulation of the Tumor Microenvironment by Epstein-Barr virus Latent Membrane Protein-1 in Nasopharyngeal Carcinoma.A generic RNA pulsed DC based approach for developing therapeutic intervention against nasopharyngeal carcinoma.Chemoradiotherapy with weekly low-dose docetaxel and cisplatin concurrent with radiation for patients with locally advanced nasopharyngeal carcinoma, followed by adjuvant chemotherapy for selected patients.miR-93 enhances cell proliferation by directly targeting CDKN1A in nasopharyngeal carcinoma.Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a.Preliminary study of differentiating smears from cancerous and non-cancerous nasopharyngeal tissue using confocal Raman spectroscopy.LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN.AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.

P2860

Q21202158-B141D90C-0CCE-40EE-AEFF-0F531BACD56A Q33655046-A799D452-B054-4981-A672-99AA25DA0FF3 Q33763893-56EEDC2D-EA61-48A6-B54E-9DEEB7D87B29 Q33813214-B86F8BD8-46E2-44FF-8745-EA7287C8F0A3 Q34582022-9BA9B66E-EB3F-48DF-9C64-A7765A05AFB3 Q34708005-101CFBD4-A4BB-42E1-A46E-536817F54906 Q35000491-EF363E72-D5DE-4A70-867D-B3E5B89B08D1 Q35051410-B2CF4C5F-279C-48CE-A8C1-972EBFC47A35 Q35079337-84BB49B5-E3A2-4481-9DD3-21618A3DCA87 Q35080861-149F53CA-4DCD-4273-B1D0-342ABD00DEEA Q35657534-A8B2B9DF-A1A8-453E-BAD9-2585AB1F6B22 Q35666538-AACD1F4F-D67E-4F0F-8C44-4C7BE8B9B1F9 Q35758037-0F4B49BD-452F-4A02-BA76-02EC92C7F9D1 Q35900248-58038A1C-F0FA-448C-BD72-1D7B0D480DFE Q36161779-75F4DD82-C940-4EE4-9397-B63614BBA678 Q36413726-13534CDD-BF4F-442F-82C4-933827E79EB4 Q36685565-2F9C450F-A49E-464A-A88F-B0246E03667E Q36716288-40D987E2-3D13-4C66-943B-036FC429155C Q37718102-C2DC4463-1D52-4A8E-8911-9E89CC1F9C26 Q38087239-F91EB4E3-098D-4843-9D21-EC5378F4E182 Q38110174-FCA689B3-8C95-4374-86AD-DEC626D323A2 Q38291362-0C30BF53-C213-4534-B13B-AB4B2BBB2CBB Q38316340-F9999C0C-157E-47C1-871C-BCF85E16226C Q38887407-95579071-62B6-4000-B80C-FF115C77F976 Q39044977-881F3EC3-7508-4E6C-8490-51A18EAE9973 Q40078689-610ABCAE-A44A-4B3C-BD33-0967B58CC863 Q40979448-B7B5974C-180D-47D9-B041-DBC47C20C482 Q42096715-429EC48C-DA25-462E-BB08-BC2E04E5A886 Q42362640-79A2FB79-178F-4B8C-96FA-4227218F3A64 Q43977483-68BBA20E-D52C-4AE9-8426-0FB4CF2AF888 Q47286778-B59E5851-F04B-4F23-BFEF-A371A69E3A10 Q48919218-CCD4500A-AB30-4798-884B-4ED25B1FB6E3 Q49148069-D3CA6D2B-2783-45F9-BF6E-A44E44175AAA Q49945184-BBC91683-C6B6-4E10-955B-6A4E1F0F96E8 Q50733282-B4647DB7-E4B6-479D-A8C7-179487704428 Q51627555-AFFBBAB1-CAE8-4572-8656-7D33F5A4485E Q52659543-DEF17D85-F982-43AA-8C38-D1874A5F84CE Q55285081-E482FB6E-7334-4805-8507-8C943C5C62B4

P2860

Current understanding and management of nasopharyngeal carcinoma.

http://www.wikidata.org/entity/Q37877020

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Current understanding and management of nasopharyngeal carcinoma.

@en

Current understanding and management of nasopharyngeal carcinoma.

@nl

type

label

Current understanding and management of nasopharyngeal carcinoma.

@en

Current understanding and management of nasopharyngeal carcinoma.

@nl

prefLabel

Current understanding and management of nasopharyngeal carcinoma.

@en

Current understanding and management of nasopharyngeal carcinoma.

@nl

P1433

Q37877020-61E0F672-0B6C-4598-B232-A5EB4D3515DF

P1476

Q37877020-035B7318-D1B8-48C5-9508-D8B2F6857FA3

P2093

Q37877020-3AA6261E-A3A9-4CB5-8CA4-777D42213AE5

Q37877020-721FFF8A-5524-4C42-A4B9-43890662D801

Q37877020-7A3FEEA7-5057-4AD4-A28F-ACE868392C55

Q37877020-8D1C8F43-0C94-47E9-8259-24C389E45395

Q37877020-DCB836AC-53D3-45C7-9EC6-0AC17FB2E174

Q37877020-F6A256EF-82C1-4A5D-805D-A287A13664A0

P304

Q37877020-E9310614-0F86-4CE7-B473-A9DB07509546

P31

Q37877020-073D951C-D502-418E-8565-D0DEE1EC2CDD

P356

Q37877020-073B2E66-FD8C-4D25-9FE0-042FF3B2E11B

P433

Q37877020-1396838C-2A59-4B9E-87DB-B1FAC8C09851

P478

Q37877020-2E7D601C-7226-4F91-B739-E7AADDC5554B

P577

Q37877020-9CE0B4DF-4991-4B0A-B2B5-171219DAFD4E

P5875

Q37877020-B2CFCE53-DA65-4093-A297-47B2A304F376

P698

Q37877020-1AE337E9-8EE1-4D98-A7CB-B9296BA0BA86

P356

J.ANL.2011.02.012

P1433

Auris Nasus Larynx

P1476

Current understanding and management of nasopharyngeal carcinoma.

@en

P2093

Kazuhira Endo

http://www.w3.org/2001/XMLSchema#string

Makoto Ito

http://www.w3.org/2001/XMLSchema#string

Naohiro Wakisaka

http://www.w3.org/2001/XMLSchema#string

Satoru Kondo

http://www.w3.org/2001/XMLSchema#string

Shigekyuki Murono

http://www.w3.org/2001/XMLSchema#string

Tomokazu Yoshizaki

http://www.w3.org/2001/XMLSchema#string

P304

137-144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ANL.2011.02.012

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51146733

http://www.w3.org/2001/XMLSchema#string

P698

21592702

http://www.w3.org/2001/XMLSchema#string